| Record 6172 View: Standard | Glossary HistCite Guide |
|
Author(s): Zjawiony JK
Title: Biologically active compounds from aphyllophorales (polypore) fungi
Source: JOURNAL OF NATURAL PRODUCTS 67 (2): 300-310
Date: 2004 FEB
Document Type: Journal : Review
DOI:
Language: English
Comment:
Address: Univ Mississippi, Res Inst Pharmaceut Sci, Sch Pharm, Dept Pharmacognosy, University, MS 38677 USA.
Univ Mississippi, Res Inst Pharmaceut Sci, Sch Pharm, Natl Ctr Nat Prod Res, University, MS 38677 USA. Reprint: Zjawiony, JK, Univ Mississippi, Res Inst Pharmaceut Sci, Sch Pharm,
Dept Pharmacognosy, University, MS 38677 USA. E-mail: jordan@olemiss.edu
Author Keywords:
KeyWords Plus:
Abstract: This review describes biologically active natural products isolated from Aphyllophorales, many of which are known as polypores. Polypores are a large group of terrestrial fungi of the phylum Basdiomycota (basidiomycetes), and they along with certain Ascomycota are a major source of pharmacologically active substances. There are about 25000 species of basidiomycetes, of which about 500 are members of the Aphyllophorales, a polyphyletic group that contains the polypores. Many of these fungi have circumboreal distributions in North America, Europe, and Asia and broad distributions on all inhabited continents and Africa; only a small number of the most common species with the most obvious fruiting bodies (basidiocarps) have been evaluated for biological activity. An estimated 75% of polypore fungi that have been tested show strong antimicrobial activity, and these may constitute a good source for developing new antibiotics. Numerous compounds from these fungi also display antiviral, cytotoxic, and/or antineoplastic activities. Additional important components of this vast arsenal of compounds are polysaccharides derived from the fungal cell walls. These compounds have attracted significant attention in recent years because of their immunomodulatory activities, resulting in antitumor effects. These high molecular weight compounds, often called biological response modifiers (BRM), or immunopotentiators, prevent carcinogenesis, show direct anticancer effects, and prevent tumor metastasis. Some of the protein-bound polysaccharides from polypores and other basidiomycetes have found their way to the market in Japan as anticancer drugs. Finally, numerous compounds with cardiovascular, phytotoxic, immunomodulatory, analgesic, antidiabetic, antioxidant, insecticidal, and nematocidal activities, isolated from polypores, are also presented. In fact many of the fungi mentioned in this paper have long been used in herbal medicine, including polypores such as Ganoderma lucidum (Reishi or Ling Zhi), Laetiporus sulphureus (Chicken-of-the-Woods), Trametes versicolor (Yun Zhi), Grifola umbellata (Zhu Lin), Inonotus obliquus (Chaga), and Wolfiporia cocos (Hoelen).
Cited References: ABATE D, 1994, J ANTIBIOT, V47, P1348 ABRAHAM WR, 2001, CURR MED CHEM, V8, P583 ALI NAA, 2003, FITOTERAPIA, V74, P483 ANKE T, 1982, Z NATURFORSCH C, V37, P1 ANKE T, 1989, PROG IND MICROBIOL, V27, P51 ANKE T, 1995, J ANTIBIOT, V48, P725 AOKI M, 1993, BIOSCI BIOTECH BIOCH, V57, P278 APPLETON RE, 1988, CMAJ, V139, P48 ATSUMI S, 1990, J ANTIBIOT, V43, P49 BRANDT CR, 2000, RRD ANTIMICROB AG 1, V4, P11 CHANG S, 1999, CURR OPIN MOL THER, V1, P139 CHEN CH, 1995, J NAT PROD, V58, P1655 CLOUGH JM, 1993, NAT PROD REP, V10, P565 COLINS RA, 1997, LIFE SCI, V60, PPL383 DEJONG E, 1994, APPL ENVIRON MICROB, V60, P264 DEKERMENDJIAN K, 1997, EUR J MED CHEM, V32, P351 DEOL BS, 1978, AUST J CHEM, V31, P1397 DESLANDES Y, 1980, MACROMOLECULES, V13, P1466 ELMEKKAWY S, 1998, PHYTOCHEMISTRY, V49, P1651 EO SK, 2001, ARCH PHARM RES, V24, P74 ERKEL G, 1996, BIOCHEM BIOPH RES CO, V226, P214 GAO JJ, 2002, CHEM PHARM BULL, V50, P837 GIANNETTI BM, 1978, Z NATURFORSCH C, V33, P807 GILBERTSON RL, 1987, N AM POLYPORES, V1 GILBERTSON RL, 1987, N AM POLYPORES, V2 HASHIMOTO T, 1998, HETEROCYCLES, V47, P1067 HAYASHI M, 1981, AGR BIOL CHEM TOKYO, V45, P1527 HIBBETT DS, 2001, MYCOTA B, V7, P121 HIROSE K, 1987, BIOCHEM BIOPH RES CO, V149, P562 HIROTANI M, 1977, TETRAHEDRON LETT, P651 HOBBS C, 1995, MEDICINAL MUSHROOMS ICHIMURA T, 1998, BIOSCI BIOTECH BIOCH, V62, P575 IKEKAWA T, 1969, CANCER RES, V29, P734 INOUE Y, 1977, CARBOHYD RES, V56, P351 ISHIZUKA M, 1972, J ANTIBIOT, V25, P320 ISHIZUKA M, 1981, J ANTIBIOT, V34, P95 KELLER AC, 1996, PHYTOCHEMISTRY, V41, P1041 KIS Z, 1970, HELV CHIM ACTA, V53, P1577 KOBAYASHI H, 1995, CANCER EPIDEM BIOMAR, V4, P275 KOBAYASHI Y, 1994, CANCER BIOTHERAPY, V9, P351 KUNIMOTO T, 1973, BIOCHIM BIOPHYS ACTA, V318, P78 KUPKA J, 1981, ARCH MICROBIOL, V130, P223 LAUER U, 1989, J ANTIBIOT, V42, P875 LEE IK, 1996, J NAT PROD, V59, P1090 LIBERRA K, 1995, PHARMAZIE, V50, P370 LIU JK, 2002, HETEROCYCLES, V57, P157 LORENZEN K, 1994, Z NATURFORSCH C, V49, P132 LORENZEN K, 1998, CURR ORG CHEM, V2, P329 LU W, 1985, CHEM PHARM BULL, V33, P5083 MANTLE PG, 1973, T BR MYCOL SOC, V61, P513 MCMORRIS TC, 1964, CAN J CHEM, V42, P1595 MELLOWS G, 1973, PHYTOCHEMISTRY, V12, P2717 MIN BS, 1998, CHEM PHARM BULL, V46, P1607 MISAKI A, 1981, CARBOHYD RES, V92, P115 MIZUNO T, 1992, BIOSCI BIOTECH BIOCH, V56, P34 MIZUNO T, 1995, FOOD REV INT, V11, P129 MIZUNO T, 1995, FOOD REV INT, V11, P179 MIZUNO T, 1995, FOOD REV INT, V11, P23 MIZUNO T, 1999, INT J MED MUSHROOMS, V1, P9 MORRISON E, 2002, J AGR FOOD CHEM, V50, P3070 MOTHANA RAA, 2000, J NAT PROD, V63, P416 MOTHANA RAA, 2003, FITOTERAPIA, V74, P177 NAIR MSR, 1975, TETRAHEDRON LETT, P2641 NAIR MSR, 1977, PHYTOCHEMISTRY, V16, P390 NAKAJIMA S, 1976, AGR BIOL CHEM TOKYO, V40, P811 NG TB, 1998, GEN PHARMACOL, V30, P1 OHSAWA T, 1992, CHEM PHARM BULL, V40, P143 OKADA M, 1987, MICROBIOL IMMUNOL, V31, P45 PEINTNER U, 1998, MYCOL RES 10, V102, P1153 QUACK W, 1978, J ANTIBIOT, V31, P737 RESHETNIKOV SV, 2001, INT J MED MUSHROOMS, V3, P361 ROBBINS WJ, 1947, P NATL ACAD SCI USA, V33, P176 ROUSSEL B, 2002, REV HIST PHARM PARIS, V50, P599 SAITO H, 1976, FEBS LETT, V68, P15 SAITO H, 1988, J GEN MICROBIOL, V134, P1029 SATO M, 2002, BIOL PHARM BULL, V25, P81 SMANIA A, 1999, INT J MED MUSHROOMS, V1, P325 SMANIA EDA, 1998, REV MICROBIOL, V29, P317 SMANIA EFA, 1997, J CHEM TECHNOL BIOT, V70, P57 SONTAG B, 1999, J NAT PROD, V62, P1425 STADLER M, 1994, J ANTIBIOT, V47, P1284 STAMETS P, 2001, HERBAL GRAM, V51, P24 STAMETS P, 2002, HERBAL GRAM, V54, P28 SU CY, 2000, THROMB RES, V99, P135 SUAY I, 2000, ANTON LEEUW INT J G, V78, P129 SUGIURA M, 1980, JPN J PHARMACOL, V30, P503 SZALLASI A, 1999, BRIT J PHARMACOL, V126, P1351 TAKEUCHI T, 1969, J ANTIBIOT, V22, P215 TAKEUCHI T, 1971, J ANTIBIOT, V24, P631 TIE Z, 1988, DICT TRADITIONAL CHI, P201 TOCHIKURA TS, 1987, BIOCHEM BIOPH RES CO, V148, P726 TOCHIKURA TS, 1989, J ACQ IMMUN DEF SYND, V2, P441 TSUKAGOSHI S, 1984, CANCER TREAT REV, V11, P131 UENO Y, 1980, CARBOHYD RES, V87, P257 UKIYA M, 2002, J NAT PROD, V65, P462 USUI T, 1981, CARBOHYD RES, V92, P109 USUI T, 1983, CARBOHYD RES, V115, P273 VALISOLALAO J, 1983, TETRAHEDRON, V39, P2779 WALDER R, 1995, ACTA CIENT VENEZ, V46, P110 WASSER PS, 2000, INT J MED MUSHROOMS, V2, P1 WASSER SP, 1999, CRIT REV IMMUNOL, V19, P65 WASSER SP, 1999, INT J MED MUSHROOMS, V1, P31 WASSER SP, 1999, INT J MED MUSHROOMS, V1, P351 WASSER SP, 2002, HERBAL GRAM, V56, P29 WEBER W, 1992, PLANTA MED, V58, P56 WEBER W, 1994, J ANTIBIOT, V47, P1188 WU TS, 2001, J NAT PROD, V64, P1121 YAMADA H, 1984, CARBOHYD RES, V125, P107 YOSHIKAWA K, 2001, CHEM PHARM BULL, V49, P327 YOSHIOKA Y, 1992, CHEM PHARM BULL, V40, P1221 YUN BS, 2002, J ANTIBIOT, V55, P208 YUNOKI S, 1994, INT J IMMUNOPHARMACO, V16, P123 |